Potential of amentoflavone with antiviral properties in COVID-19 treatment

[1] Lee DYW, Li QY, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Phytomedicine. 2021; 80:153337. doi: 10.1016/j.phymed.2020.153337 LeeDYW LiQY LiuJ EfferthT Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis Phytomedicine 2021 80 153337 10.1016/j.phymed.2020.153337 752188433221457 Open DOISearch in Google Scholar

[2] World Health Organization. Expert panel endorses protocol for COVID-19 herbal medicine clinical trials [internet]. Brazzaville, Republic of Congo: World Health Organization - Regional Office for Africa; 2020 [cited 2020 November 28]. Available from: https://www.afro.who.int/news/expert-panel-endorses-protocol-covid-19-herbal-medicine-clinical-trials World Health Organization Expert panel endorses protocol for COVID-19 herbal medicine clinical trials [internet] Brazzaville, Republic of Congo World Health Organization - Regional Office for Africa 2020 [cited 2020 November 28]. Available from: https://www.afro.who.int/news/expert-panel-endorses-protocol-covid-19-herbal-medicine-clinical-trials Search in Google Scholar

[3] Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo GL. Roles of flavonoids against coronavirus infection. Chem Biol Interact. 2020; 328:109211. doi: 10.1016/j.cbi.2020.109211 RussoM MocciaS SpagnuoloC TedescoI RussoGL Roles of flavonoids against coronavirus infection Chem Biol Interact 2020 328 109211 10.1016/j.cbi.2020.109211 738553832735799 Open DOISearch in Google Scholar

[4] Peterson L. COVID-19 and flavonoids: in silico molecular dynamics docking to the active catalytic site of SARS-CoV and SARS-CoV-2 main protease. SSRN Electronic J. 2020. doi: 10.2139/ssrn.3599426 PetersonL COVID-19 and flavonoids: in silico molecular dynamics docking to the active catalytic site of SARS-CoV and SARS-CoV-2 main protease SSRN Electronic J 2020 10.2139/ssrn.3599426 Open DOISearch in Google Scholar

[5] Jahan I, Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turkish J Biol 2020; 44(Special Issue 1):228–41. JahanI OnayA Potentials of plant-based substance to inhabit and probable cure for the COVID-19 Turkish J Biol 2020 44 Special Issue 1 228 41 10.3906/biy-2005-114731451432595359 Search in Google Scholar

[6] Orhan IE, Senol Deniz FS. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Nat Products Bioprospect. 2020; 10:171–86. OrhanIE Senol DenizFS Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Nat Products Bioprospect 2020 10 171 86 10.1007/s13659-020-00250-4728922932529545 Search in Google Scholar

[7] Benarba B, Pandiella A. Medicinal plants as sources of active molecules against COVID-19. Front Pharmacol. 2020; 11:1–16. BenarbaB PandiellaA Medicinal plants as sources of active molecules against COVID-19 Front Pharmacol 2020 11 1 16 10.3389/fphar.2020.01189742746632848790 Search in Google Scholar

[8] Yu S, Yan H, Zhang L, Shan M, Chen P, Ding A, Li SF. A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid. Molecules. 2017; 22:299. doi: 10.3390/molecules22020299 YuS YanH ZhangL ShanM ChenP DingA LiSF A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid Molecules 2017 22 299 10.3390/molecules22020299 615557428212342 Open DOISearch in Google Scholar

[9] Chen T-R, Wei L-H, Guan X-Q, Huang C, Liu Z-Y, Wang F-J, et al. Biflavones from Ginkgo biloba as inhibitors of human thrombin. Bioorg Chem. 2019; 92:103199. doi: 10.1016/j.bioorg.2019.103199 ChenT-R WeiL-H GuanX-Q HuangC LiuZ-Y WangF-J Biflavones from Ginkgo biloba as inhibitors of human thrombin Bioorg Chem 2019 92 103199 10.1016/j.bioorg.2019.103199 31446241 Open DOISearch in Google Scholar

[10] Ma S-C, But PP-H, Ooi VE-C, He Y-H, Lee SH-S, Lee S-F, Lin R-C. Antiviral amentoflavone from Selaginella sinensis. Biol Pharm Bull. 2001; 24:311–2. MaS-C ButPP-H OoiVE-C HeY-H LeeSH-S LeeS-F LinR-C Antiviral amentoflavone from Selaginella sinensis Biol Pharm Bull 2001 24 311 2 10.1248/bpb.24.31111256492 Search in Google Scholar

[11] Li F, Song X, Su G, Wang Y, Wang Z, Jia J, et al. Amentoflavone inhibits HSV-1 and ACV-resistant strain infection by suppressing viral early infection. Viruses 2019; 11:466. doi: 10.3390/v11050466. LiF SongX SuG WangY WangZ JiaJ Amentoflavone inhibits HSV-1 and ACV-resistant strain infection by suppressing viral early infection Viruses 2019 11 466 10.3390/v11050466. Open DOISearch in Google Scholar

[12] Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Inhibitory effects of amentoflavone and orobol on daclatasvir-induced resistance-associated variants of hepatitis C virus. Am J Chin Med. 2018; 46:835–52. LeeWP LanKL LiaoSX HuangYH HouMC LanKH Inhibitory effects of amentoflavone and orobol on daclatasvir-induced resistance-associated variants of hepatitis C virus Am J Chin Med 2018 46 835 52 10.1142/S0192415X1850044129737209 Search in Google Scholar

[13] Wilsky S, Sobotta K, Wiesener N, Pilas J, Althof N, Munder T, et al. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch Virol. 2012; 157:259–69. WilskyS SobottaK WiesenerN PilasJ AlthofN MunderT Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication Arch Virol 2012 157 259 69 10.1007/s00705-011-1164-z22075919 Search in Google Scholar

[14] Coulerie P, Nour M, Maciuk A, Eydoux C, Guillemot J-C, Lebouvier N, et al. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp. Planta Med. 2013; 79:1313–8. CoulerieP NourM MaciukA EydouxC GuillemotJ-C LebouvierN Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp Planta Med 2013 79 1313 8 10.1055/s-0033-135067223929244 Search in Google Scholar

[15] Bhargava S, Patel T, Gaikwad R, Patil UK, Gayen S. Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR Simulation. Nat Prod Res. 2019;33:851–7. BhargavaS PatelT GaikwadR PatilUK GayenS Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR Simulation Nat Prod Res 2019 33 851 7 10.1080/14786419.2017.141357429241370 Search in Google Scholar

[16] Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorganic Med Chem Lett. 2020; 30:127377. doi: 10.1016/j.bmcl.2020.127377 UllrichS NitscheC The SARS-CoV-2 main protease as drug target Bioorganic Med Chem Lett 2020 30 127377 10.1016/j.bmcl.2020.127377 733156732738988 Open DOISearch in Google Scholar

[17] Ryu YB, Jeong HJ, Kim JH, Kim YM, Park JY, Kim D, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorganic Med Chem 2010; 18:7940–7. RyuYB JeongHJ KimJH KimYM ParkJY KimD Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition Bioorganic Med Chem 2010 18 7940 7 10.1016/j.bmc.2010.09.035712630920934345 Search in Google Scholar

[18] Jo S, Kim S, Shin DH, Kim M-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem. 2020;35:145–51. JoS KimS ShinDH KimM-S Inhibition of SARS-CoV 3CL protease by flavonoids J Enzyme Inhib Med Chem 2020 35 145 51 10.1080/14756366.2019.1690480688243431724441 Search in Google Scholar

[19] Mishra A, Pathak Y, Kumar A, Mishra SK, Tripathi V. Natural compounds as potential inhibitors of SARS-CoV-2 main protease: an in-silico study. Asian Pac J Trop Biomed. 2021; 11:155–63. MishraA PathakY KumarA MishraSK TripathiV Natural compounds as potential inhibitors of SARS-CoV-2 main protease: an in-silico study Asian Pac J Trop Biomed 2021 11 155 63 10.4103/2221-1691.310202 Search in Google Scholar

[20] Miroshnychenko KV. Shestopalova A. Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. J Biomol Struct Dyn. 2021 Apr 26;1–15. [Online ahead of print]. doi: 10.1080/07391102.2021.1914168 MiroshnychenkoKV ShestopalovaA Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study J Biomol Struct Dyn 2021 Apr 26 1 15 [Online ahead of print] 10.1080/07391102.2021.1914168 807465333896392 Open DOISearch in Google Scholar

[21] National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. Bethesda, MD: National Institutes of Health; 2021 [cited 2021 July 13]. Available at: https://www.covid19treatmentguidelines.nih.gov/ National Institutes of Health COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet] Bethesda, MD National Institutes of Health 2021 [cited 2021 July 13]. Available at: https://www.covid19treatmentguidelines.nih.gov/ Search in Google Scholar

[22] Iannaccone G, Scacciavillani R, Del Buono MG, Camilli M, Ronco C, Lavie CJ, et al. Weathering the cytokine storm in COVID-19: therapeutic implications. Cardiorenal Med. 2020; 10:277–87. IannacconeG ScacciavillaniR Del BuonoMG CamilliM RoncoC LavieCJ Weathering the cytokine storm in COVID-19: therapeutic implications Cardiorenal Med 2020 10 277 87 10.1159/000509483736050732599589 Search in Google Scholar

[23] Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J. 2020; 56:2002049. doi: 10.1183/13993003.02049-2020 Torres AcostaMA SingerBD Pathogenesis of COVID-19-induced ARDS: implications for an ageing population Eur Respir J 2020 56 2002049 10.1183/13993003.02049-2020 739794532747391 Open DOISearch in Google Scholar

[24] Diniz LRL, Bezerra Filho CdSM, Fielding BC, de Sousa DP. Natural antioxidants: a review of studies on human and animal coronavirus. Oxid Med Cell Longev 2020; 2020:3173281. doi: 10.1155/2020/3173281 DinizLRL Bezerra FilhoCdSM FieldingBC de SousaDP Natural antioxidants: a review of studies on human and animal coronavirus Oxid Med Cell Longev 2020 2020 3173281 10.1155/2020/3173281 744322932855764 Open DOISearch in Google Scholar

[25] Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43(D1):D447–52. SzklarczykD FranceschiniA WyderS ForslundK HellerD Huerta-CepasJ STRING v10: protein–protein interaction networks, integrated over the tree of life Nucleic Acids Res 2015 43 D1 D447 52 10.1093/nar/gku1003438387425352553 Search in Google Scholar

[26] Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: Augmenting protein–chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016; 44(D1):D380–4. SzklarczykD SantosA von MeringC JensenLJ BorkP KuhnM STITCH 5: Augmenting protein–chemical interaction networks with tissue and affinity data Nucleic Acids Res 2016 44 D1 D380 4 10.1093/nar/gkv1277470290426590256 Search in Google Scholar

[27] Oh J, Rho HS, Yang Y, Yoon JY, Lee J, Hong YD, et al. Extracellular signal-regulated kinase is a direct target of the anti-inflammatory compound amentoflavone derived from Torreya nucifera. Mediators Inflamm. 2013; 2013:761506. doi: 10.1155/2013/761506. OhJ RhoHS YangY YoonJY LeeJ HongYD Extracellular signal-regulated kinase is a direct target of the anti-inflammatory compound amentoflavone derived from Torreya nucifera Mediators Inflamm 2013 2013 761506 10.1155/2013/761506. Open DOISearch in Google Scholar

[28] Zong Y, Zhang H. Amentoflavone prevents sepsis-associated acute lung injury through Nrf2-GCLc-mediated upregulation of glutathione. Acta Biochim Pol. 2017; 64:93–8. ZongY ZhangH Amentoflavone prevents sepsis-associated acute lung injury through Nrf2-GCLc-mediated upregulation of glutathione Acta Biochim Pol 2017 64 93 8 10.18388/abp.2016_129627718499 Search in Google Scholar

[29] Cai J, Zhao C, Du Y, Huang Y, Zhao Q. Amentoflavone ameliorates cold stress-induced inflammation in lung by suppression of C3/BCR/NF-κB pathways. BMC Immunol. 2019; 20:49. doi: 10.1186/s12865-019-0331-y CaiJ ZhaoC DuY HuangY ZhaoQ Amentoflavone ameliorates cold stress-induced inflammation in lung by suppression of C3/BCR/NF-κB pathways BMC Immunol 2019 20 49 10.1186/s12865-019-0331-y 693796131888465 Open DOISearch in Google Scholar

[30] Gan L, Ma J, You G, Mai J, Wang Z, Yang R, et al. Glucuronidation and its effect on the bioactivity of amentoflavone, a biflavonoid from Ginkgo biloba leaves. J Pharm Pharmacol. 2020; 72:1840–53. GanL MaJ YouG MaiJ WangZ YangR Glucuronidation and its effect on the bioactivity of amentoflavone, a biflavonoid from Ginkgo biloba leaves J Pharm Pharmacol 2020 72 1840 53 10.1111/jphp.1324732144952 Search in Google Scholar

[31] Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol. 2010; 48:429–35. KimuraY ItoH OhnishiR HatanoT Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity Food Chem Toxicol 2010 48 429 35 10.1016/j.fct.2009.10.04119883715 Search in Google Scholar

[32] Park S-Y, Nguyen P-H, Kim G, Jang S-N, Lee G-H, Phuc NM, et al. Strong and selective inhibitory effects of the biflavonoid selamariscina A against CYP2C8 and CYP2C9 enzyme activities in human liver microsomes. Pharmaceutics. 2020; 12:343. doi: 10.3390/pharmaceutics12040343 ParkS-Y NguyenP-H KimG JangS-N LeeG-H PhucNM Strong and selective inhibitory effects of the biflavonoid selamariscina A against CYP2C8 and CYP2C9 enzyme activities in human liver microsomes Pharmaceutics 2020 12 343 10.3390/pharmaceutics12040343 723812032290339 Open DOISearch in Google Scholar

[33] Pan X, Tan N, Zeng G, Zhang Y, Jia R. Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B. Bioorganic Med Chem. 2005; 13:5819–25. PanX TanN ZengG ZhangY JiaR Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B Bioorganic Med Chem 2005 13 5819 25 10.1016/j.bmc.2005.05.07116084098 Search in Google Scholar

[34] Lv X, Zhang J-B, Wang X-X, Hu W-Z, Shi Y-S, Liu S-W, et al. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases. Chem Biol Interact. 2018;284:48–55. LvX ZhangJ-B WangX-X HuW-Z ShiY-S LiuS-W Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases Chem Biol Interact 2018 284 48 55 10.1016/j.cbi.2018.02.00929470958 Search in Google Scholar

[35] Ananchaisarp T, Rungruang S, Theerakulpisut S, Kamsakul P, Nilbupha N, Chansawangphop N, et al. Usage of herbal medicines among the elderly in a primary care unit in Hat Yai, Songkhla province, Thailand. Asian Biomed (Res Rev News) 2021; 15:35–42. AnanchaisarpT RungruangS TheerakulpisutS KamsakulP NilbuphaN ChansawangphopN Usage of herbal medicines among the elderly in a primary care unit in Hat Yai, Songkhla province, Thailand Asian Biomed (Res Rev News) 2021 15 35 42 10.2478/abm-2020-0005 Search in Google Scholar

[36] Stolbach A, Paziana K, Heverling H, Pham P. A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products. J Med Toxicol. 2015; 11:326–41. StolbachA PazianaK HeverlingH PhamP A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products J Med Toxicol 2015 11 326 41 10.1007/s13181-015-0465-0454796626036354 Search in Google Scholar

[37] Borrelli F, Izzo AA. Herb–drug interactions with St John's Wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009; 11:710–27. BorrelliF IzzoAA Herb–drug interactions with St John's Wort (Hypericum perforatum): an update on clinical observations AAPS J 2009 11 710 27 10.1208/s12248-009-9146-8278208019859815 Search in Google Scholar

[38] Lobstein-Guth A, Briançon-Scheid F, Victoire C, Haag-Berrurier M, Anton R. Isolation of amentoflavone from Ginkgo biloba. Planta Med. 1988; 54:555–6. Lobstein-GuthA Briançon-ScheidF VictoireC Haag-BerrurierM AntonR Isolation of amentoflavone from Ginkgo biloba Planta Med 1988 54 555 6 10.1055/s-2006-9625493212094 Search in Google Scholar

[39] Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry. 1997; 30:129–34. NahrstedtA ButterweckV Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 1997 30 129 34 10.1055/s-2007-9795339342774 Search in Google Scholar

[40] Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. J Pharm Pharmacol. 2019; 71:129–38. Chrubasik-HausmannS VlachojannisJ McLachlanAJ Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content J Pharm Pharmacol 2019 71 129 38 10.1111/jphp.1285829411879 Search in Google Scholar

[41] Deng Y, Bi H-C, Zhao L-Z, He F, Liu Y-Q, Yu J-J, et al. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats. Xenobiotica 2008; 38:465–81. DengY BiH-C ZhaoL-Z HeF LiuY-Q YuJ-J Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats Xenobiotica 2008 38 465 81 10.1080/0049825070188323318421621 Search in Google Scholar

[42] Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 323:1824–36. SandersJM MonogueML JodlowskiTZ CutrellJB Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review JAMA 2020 323 1824 36 10.1001/jama.2020.601932282022 Search in Google Scholar

[43] Huynh T, Wang H, Cornell W, Luan B. In silico exploration of repurposing and optimizing traditional Chinese medicine rutin for possibly inhibiting SARS-CoV-2's main protease. ChemRxiv. Preprint. 2020. doi: 10.26434/chemrxiv.12281078.v1 HuynhT WangH CornellW LuanB In silico exploration of repurposing and optimizing traditional Chinese medicine rutin for possibly inhibiting SARS-CoV-2's main protease ChemRxiv. Preprint 2020 10.26434/chemrxiv.12281078.v1 Open DOISearch in Google Scholar